CGTX
CGTX
US19243B1026
Cognition Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
83.39M EUR
109.31M EUR
67.91M EUR
120.02M EUR
Enterprise Value
51.7M EUR
75.89M EUR
37.24M EUR
83.85M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-3.99x
--
--
--
Price to Sales
--
--
--
--
Price to Book
2.53x
3.31x
2.27x
3.5x
EV/Revenue
--
--
--
--
EV/EBITDA
-1.42x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-28.72%
-16.19%
-29.82%
-12.26%
ende